MedPath

"Investigation of the Relationship Between New Coronary Virus Disease (COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women"

Completed
Conditions
Depression, Postpartum
COVID
Anxiety
Registration Number
NCT04384887
Lead Sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Brief Summary

In our study; Anxiety and depression levels, socio-demographic characteristics of the pregnant women who were admitted to our hospital between 25.04.2020-25.07.2020 and treated with the diagnosis of covid 19, and the change in anxiety and depression levelsWİTH Beck Depression and Anxiety Score after the disease regressed are planned.

(Beck depression scale contains 10 questions and a total of 1 to 100 points is obtained. High score indicates that depression and anxiety are high.) 0-16 points = mild depressive symptoms

17-29 points = moderate depressive symptoms

30-63 points = severe depressive symptoms

Detailed Description

The sociodemographic data form prepared by the researchers will be filled out by interviewing the patients who are willing to participate in the study. In addition, Beck Depression Scale, Beck Anxiety Scale, State and Trait Anxiety Scale will be given by the participants themselves. When the patients come to their first control after discharge, the scales specified will be repeated.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • covid -19 pcr positive pregnant women
  • no psychiatric diagnosis no use of psychiatric medicine
Read More
Exclusion Criteria

Non-pregnant patients, A psychiatric diagnosis use of psychiatric medicine

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of depression and anxiety score changes of covid-19 positive pregnants4 months

Evaluation of depression and anxiety score changes of covid-19 positive pregnants Pregnant women are questioned how this period was affected, as the pandemic period loaded with extra stress and caused depression and anxiety.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Pinar Yalcin Bahat

🇹🇷

Istanbul, İ̇stanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath